ClinicalTrials.gg
RecruitingNCT05511012LOBACOMUpdated Jun 11, 2026

Does the Therapist's Assessment of Movement Control in Low Back Pain Patients Correspond to an Objective Kinematic Modification

An interventional study of motion control fault tests in Chronic Low-back Pain, sponsored by University Hospital, Brest. Recruiting at 1 site in France. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-06-11.

Sponsored by University Hospital, Brest · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Started Dec 2022; still recruiting 3 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years to 99 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 114 studies in Low Back Pain with a site in France — 30 open to participants now, 33 under way, 5 of them phase 3. Low Back Pain · France.

Planned enrollment
48th of 79
50 · median 82
Started
2022
with 12 others
No phase
61 of 114
21 open now
Primary completion
2026-12
later than 12 of 32 live
Registered
74th of 114
by date
Lead sponsor
4 of 114
University Hospital, Brest

Among the 114 studies in Low Back Pain with a site in France, this one is the 48th largest by planned enrollment of the 79 interventional ones that give a count, is one of 13 that started in 2022, is one of 61 with no phase, reaches primary completion later than 12 of the 32 other live ones, and was the 74th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

30 of the 114 studies in Low Back Pain with a site in France are open now. Recruiting first, the newest first:

24 more — sign in →

All 30 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 99 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 114 studies in Low Back Pain with a site in France, or all of them as a file.
02

Study summary

  • Exercise-based treatment is part of the recommendations for good practice in the treatment of low back pain (acute, sub-acute and chronic).
  • The low back pain population is heterogeneous. This heterogeneity would cause the positive effects of a treatment to be canceled out by the negative effects of another part of the population.
  • This polymorphism has led several authors to classify low back pain into subgroups. These subgroups constitute more homogeneous clinical pictures and would facilitate the adaptation of treatments.
  • The recommendations of the American Physical Therapy Association suggest 5 subgroups of low back pain. One of them is "low back pain with movement coordination defect". In this subgroup, Luomajoki studied the reliability of different functional tests used in clinical practice. 6 out of 10 motion control fault tests show good reliability.
  • The quantified analysis of the movement of low back pain patients would make it possible to determine the sensitivity of detecting an anomaly in the 6 lumbar movement control tests.
Read the detailed description
  • Exercise-based treatment is part of the recommendations for good practice in the treatment of low back pain (acute, sub-acute and chronic).
  • The low back pain population is heterogeneous. This heterogeneity would cause the positive effects of a treatment to be canceled out by the negative effects of another part of the population.
  • This polymorphism has led several authors to classify low back pain into subgroups. These subgroups constitute more homogeneous clinical pictures and would facilitate the adaptation of treatments.
  • The recommendations of the American Physical Therapy Association suggest 5 subgroups of low back pain. One of them is "low back pain with movement control impairment". In this subgroup, Luomajoki studied the reliability of different functional tests used in clinical practice. 6 out of 10 motion control fault tests show good reliability.
  • The quantified analysis of the movement of low back pain patients would make it possible to determine the sensitivity of detecting an anomaly in the 6 lumbar movement control tests.

LoBaCoM is a monocentric, exploratory prospective study.

The purpose is to define a kinematic (angular) threshold corresponding to an anomaly detected clinically by three therapists for each test.

03

Conditions studied

  • Chronic Low-back Pain

Browse trials for

Keywords

  • Low back pain
  • Movement control
  • Kinematic analysis
  • Clinical assessment
04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged more than 18 years
  • Common low back pain with medical prescription for rehabilitation
  • Signed consent
  • Be affiliated to a social security scheme
  • Be able to perform the lumbar motion control failure tests

Exclusion criteria

Exclusion Criteria:

  • greater than 30 (obesity)
  • Person who does not understand French
  • Pregnant woman
  • Refusal to participate
  • Volunteer under guardianship or curatorship
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Other
    motion control fault testing

    Each patient make six motion control fault tests in the same order : 1. "waiters bow" 2. "pelvic tilt" 3. "one leg stance" 4. "sitting knee extension" 5. "rocking 4 point kneeling" 6. "prone knee bend" This tests are performed three times.

    Other: motion control fault tests

Interventions

  • Othermotion control fault tests

    Patients make 6 motion control fault tests, in the same order. Each test is performed three times

06

What researchers measure

Primary outcomes

  1. Range of compensation motion : "waiters bow" test

    Lumbar flexion measured for test number 1 "waiters bow". Patients are filmed during the test. Videos are watched by three physiotherapists. They going to establish a diagnostic normal or abnormal

    Time frame: Day 0

  2. Range of compensation motion : "pelvic tilt" test

    thoracic flexion measured for test number 2 "pelvic tilt". Patients are filmed during the test. Videos are watched by three physiotherapists. They going to establish a diagnostic normal or abnormal.

    Time frame: Day 0

  3. Range of compensation motion : "One leg stance" test

    Pelvic shift measured for test number 3 "One leg stance ". Patients are filmed during the test. Videos are watched by three physiotherapists. They going to establish a diagnostic normal or abnormal.

    Time frame: Day 0

  4. Range of compensation motion : "sitting knee extension" test

    Lumbar flexion measured for test number 4 "sitting knee extension". Patients are filmed during the test. Videos are watched by three physiotherapists. They going to establish a diagnostic normal or abnormal.

    Time frame: Day 0

  5. Range of compensation motion : "rocking 4 point kneeling" test

    Lumbar flexion and extension measured for test number 5 "rocking 4 point kneeling ". Patients are filmed during the test. Videos are watched by three physiotherapists. They going to establish a diagnostic normal or abnormal.

    Time frame: Day 0

  6. Range of compensation motion : "prone knee bend" test

    Lumbar extension measured for test number 6 "prone knee bend". Patients are filmed during the test. Videos are watched by three physiotherapists. They going to establish a diagnostic normal or abnormal

    Time frame: Day 0

Secondary outcomes

  1. Speed of execution for test 1

    It is measured with a camera. The camera can film one hundred pictures per second. Speed of execution is measured in seconds.

    Time frame: Day 0

  2. Speed of execution for test 2

    It is measured with a camera. The camera can film one hundred pictures per second. Speed of execution is measured in seconds.

    Time frame: Day 0

  3. Speed of execution for test 3

    It is measured with a camera. The camera can film one hundred pictures per second. Speed of execution is measured in seconds.

    Time frame: Day 0

  4. Speed of execution for test 4

    It is measured with a camera. The camera can film one hundred pictures per second. Speed of execution is measured in seconds.

    Time frame: Day 0

  5. Speed of execution for test 5

    It is measured with a camera. The camera can film one hundred pictures per second. Speed of execution is measured in seconds.

    Time frame: Day 0

  6. Speed of execution for test 6

    It is measured with a camera. The camera can film one hundred pictures per second. Speed of execution is measured in seconds.

    Time frame: Day 0

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All collected data that underlie results in a publication

Supporting information: Study protocol

Time frame: Data will be available after the publication of result and ending fifteen years following the last visit of the last patient

Access criteria: Data access requests will be reviewed by the internal committee of Brest University Hospital. Requestors will be required to sign and complete a data access agreement.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2022 (actual). Primary completion is estimated for Dec 2026, 48 months after the start.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 48 months is above that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 19, 2022
First posted
Aug 22, 2022
StartActual
Dec 15, 2022
Primary completionEst.
Dec 15, 2026
CompletionEst.
Dec 15, 2026
Last update
Jun 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05511012
Responsible party
Sponsor
First posted
Aug 22, 2022
Start date
Dec 15, 2022
Primary completion
Dec 15, 2026 (estimated)
Completion
Dec 15, 2026 (estimated)
Last update
Jun 11, 2026

Study contacts

Vincent CREAC'H
Contact
vincent.creach@univ-brest.fr
+33(0)298017935

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion